| The Pharmaceutical Journal |
||
|
PDF 50K |
|
CPD
|
The SocietyFinancial questionsFrom Mr I. M. Caldwell, FRPharmS The report (PJ, 17 August, p228) on the costs of the President's new flat is somewhat simplistic in its understatement of the true cost to the balance sheet. As I have written in the past, the expenditure of some £600,000 on the purchase of a lease results in a loss of income to the Royal Pharmaceutical Society of at least £30,000 per annum even in these days of abysmal interest rates. If this is added to the indicated running costs and the total set against the reported savings on 24-hour security of £40,000, the result is at best cost-neutral, not a saving. I also find it unclear as to whether the reported saving on our museum activities is gross or is exclusive of the costs of packing, transport and storage on a secure site. I am intrigued by the suggestion that what I assumed was a "one-off" saving resulting from a cessation of a service to members will in future continue to generate an ever increasing saving, ie, next year we will save 13.5 per cent more, and that no account is given of the redundancy costs. I also understand that the Society will continue to be liable for storage charges on a unique collection which is no longer available for inspection. Ian Caldwell
|
|||
|
Send your letter to The Editor |
Previous
Topic (Health education) |
Home | Journals | News | Notice-board | Search | Jobs Classifieds | Site
Map | Contact us
©The Pharmaceutical Journal